Cytodyn Inc (CYDY)

[justdafactss]

Looks like possible trouble or bad news for CYDY's PDUFA date for today-


https://www.fdatracker.com/fda-calendar/

VANCOUVER, Washington, June 08, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the U.S. Food and Drug Administration (FDA) advised the Company, subject to its ongoing review, it could receive its “PDUFA date” on July 10, 2020.

Under the Prescription Drug User Fee Act (PDUFA), the FDA sets a goal date for the agency to complete its review of a new drug application; this date is commonly referred to as the “PDUFA date.” The FDA’s standard review time for new drug applications is 10 months. The Company’s drug candidate, leronlimab, was previously granted Fast Track designation by the FDA and the BLA was granted rolling review. The Company recently filed for Priority Review designation with the intent to reduce the FDA’s review time to six months. The FDA informs the applicant of a Priority Review designation within 60 days.
https://www.globenewswire.com/news-release/2020/06/08/2044758/0/en/CytoDyn-Receives-BLA-Acknowledgment-Letter-From-the-FDA.html